Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cross-training program for cancer survivors

Official title: Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Study of CrossFit® in Cancer Survivors

Run by Barbara Ann Karmanos Cancer Institute · NCT03750981 · Data updated 2026-11-12

This study is testing a 12-week workout program for cancer survivors to see if it can improve their fitness, body shape, and overall quality of life compared to standard guidelines.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorBarbara Ann Karmanos Cancer Institute
Academic / other
Locations1 site (Detroit, Michigan)
StatusRecruiting
StartedNovember 12, 2018
Main results expectedNovember 30, 2027
Study endsNovember 30, 2028
Registry record updatedNovember 6, 2025
Trial IDNCT03750981 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have been diagnosed with invasive cancer and have received clearance from their physician to participate.

Probably not a fit

Patients currently undergoing treatment for cancer may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot intervention introduces a 12-week high-intensity functional training program for cancer survivors, aiming to enhance their functional performance, body composition, and quality of life compared to existing American Cancer Society guidelines. The study will involve 100 participants who will undergo weekly surveys and monthly physical assessments to evaluate the program's effectiveness. Additionally, the study will explore recruitment methods and barriers to participation, as well as participant satisfaction among those who complete the program. The findings will help refine methods for a larger future study.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and physical health of cancer survivors.

How similar studies have gone: While this approach is innovative, similar studies have shown positive outcomes in improving quality of life for cancer survivors through physical activity interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or older at time of program recruitment
* Diagnosed with any cancer
* Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
* Available transportation to and from the facility on session days

Exclusion Criteria

* Widely metastatic cancers to the brain or bone may be excluded.
* Patients using mobility assistance devices may be excluded. Exclusionary criteria will be reviewed on a case-by-case basis and patients with these limitations may be included with approval from Dr. Beebe-Dimmer and the referring physician.

Where it's running

  • Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Jennifer Beebe-Dimmer, MPH, PhD. — Barbara Ann Karmanos Cancer Institute
  • Study coordinator: Jennifer B Beebe-Dimmer, MPH, PhD.
  • Email: dimmerj@karmanos.org
  • Phone: (313) 578-4209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.